Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

BioBalanced

Financiado

Feasibility study for Bioapplications BioBalanced Farm probiotic

A rapid emergence of resistant bacteria occurs worldwide, endangering the efficacy of antibiotics, which have transformed medicine and saved millions of lives. The antibiotic resistance crisis has been attributed to the overuse an... ver más

31/12/2018

Bioapp

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

UAB BIOAPPLICATIONS No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2018-12-31

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 6 años

0% 100%

2 Participantes

Bioapp

50.00K€ | Lider

QUANTUM EXPERIMENTAL

328.10K€ | Participante

Últimas noticias

27-11-2024: Videojuegos y creaci... Se abre la línea de ayuda pública: Ayudas para la promoción del sector del videojuego, del pódcast y otras formas de creación digital

27-11-2024: DGIPYME En las últimas 48 horas el Organismo DGIPYME ha otorgado 1 concesiones

27-11-2024: FUNDACION-EOI En las últimas 48 horas el Organismo FUNDACION EOI ha otorgado 2 concesiones

Duración del proyecto: 5 meses Fecha Inicio: 2018-07-18
Fecha Fin: 2018-12-31

Líder del proyecto

UAB BIOAPPLICATIONS

TRL 4-5

Presupuesto del proyecto 71K€

Descripción del proyecto A rapid emergence of resistant bacteria occurs worldwide, endangering the efficacy of antibiotics, which have transformed medicine and saved millions of lives. The antibiotic resistance crisis has been attributed to the overuse and misuse of these medications. 700 000 patients die annually as a result of infections caused by antibiotic resistant bacteria. Due to a growing demand to substitute medicine and hazardous chemical usage in agriculture, Bioapplications developed the BioBalanced Farm Probiotic – a unique probiotics blend, which is misted in the facility, naturally excludes pathogenic bacteria and prevent mutation and development of resistant bacteria. The Solution also strengthens immune system, improves the welfare and increases the mass of the livestock, reduces bad odours, and generally improves a quality of meat. Consequently, farmers are able to fight. According to Eurostat, there were 331.16 million Livestock Units (LSUs) in 2017 – 44.47% were pigs, 26.9% were cows, 26.3% were sheep’s and 3.9% were goats. Since pigs are the most prevalent in Europe and antibiotics are heavily overused in pig farms, the commercialisation of the solution will be firstly focused on pig farms. With a total of 147.24 M pigs in EU-E8, the total available market size for BioBalanced Farm probiotic is 88.34 M square meters. Bioapplications will enter the market by targeting large pig farms in home market Denmark, followed by Spain, Germany, the Netherlands and Belgium. After a successful commercialisation, Bioapplications plans to scale-up by expanding into other EU regions and providing the service to poultry and cows farms. Commercialisation strategy includes three steps: preparation for market entry (home markets), market replication (large pig farms in target countries) and scaling-up (large pigs/poultry/cow farms in other EU countries). The Solution developed by Bioapplications is currently at TRL 6: prototype that is validated in industrially relevant environment stag

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores